Safety, Tolerability and Pharmacokinetics of LNK01004 Ointment in Adults With Atopic Dermatitis.
Clinical trial NCT06553287 · COMPLETED
Trial details
- NCT number
- NCT06553287
- Sponsor
- Lynk Pharmaceuticals Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-12
- Primary completion
- 2024-06-18
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.